Get Jakafi (Ruxolitinib) Covered by Cigna in New Jersey: PA Forms, Appeals & Cost Assistance
Answer Box: Fastest Path to Jakafi Coverage with Cigna in New Jersey
Jakafi (ruxolitinib) requires prior authorization from Cigna and is typically covered for FDA-approved indications (myelofibrosis, polycythemia vera, GVHD) when clinical criteria are met. Your prescriber must submit a PA request through Cigna's provider portal with documentation